| Literature DB >> 32722609 |
JoEllen M Sefton1, Kaitlin D Lyons1, Darren T Beck2,3, Cody T Haun2,4, Matthew A Romero2, Petey W Mumford2, Paul A Roberson2, Kaelin C Young2,3, Michael D Roberts2,3, Jeremy S McAdam1,5.
Abstract
Training civilians to be soldiers is a challenging task often resulting in musculoskeletal injuries, especially bone stress injuries. This study evaluated bone health biomarkers (P1NP/CTX) and whey protein or carbohydrate supplementations before and after Army initial entry training (IET). Ninety male IET soldiers participated in this placebo-controlled, double-blind study assessing carbohydrate and whey protein supplementations. Age and fat mass predicted bone formation when controlling for ethnicity, explaining 44% (p < 0.01) of bone formation variations. Age was the only significant predictor of bone resorption (p = 0.02) when controlling for run, fat, and ethnicity, and these factors together explained 32% of the variance in bone resorption during week one (p < 0.01). Vitamin D increased across training (p < 0.01). There was no group by time interaction for supplementation and bone formation (p = 0.75), resorption (p = 0.73), Vitamin D (p = 0.36), or calcium (p = 0.64), indicating no influence of a supplementation on bone biomarkers across training. Age, fitness, fat mass, and ethnicity were important predictors of bone metabolism. The bone resorption/formation ratio suggests IET soldiers are at risk of stress injuries. Male IET soldiers are mildly to moderately deficient in vitamin D and slightly deficient in calcium throughout training. Whey protein or carbohydrate supplementations did not affect the markers of bone metabolism.Entities:
Keywords: biomarker; bone injury; injury prevention; military training; musculoskeletal injury; stress fracture
Year: 2020 PMID: 32722609 PMCID: PMC7468883 DOI: 10.3390/nu12082225
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Figure 1Grouping of the participants. WP: whey protein and CHO: carbohydrate.
Week 1 characteristics by ethnicity.
| Variable | Caucasian (N = 36) | Other (N = 54) | Combined (N = 90) | |
|---|---|---|---|---|
|
| 0.52 | |||
| Mean (SD) | 21.806 (3.54) | 22.30 (3.50) | 22.10 (3.51) | |
| Range | 18.00–35.00 | 18.00–32.00 | 18.00–35.000 | |
|
| 0.002 | |||
| Mean (SD) | 176.97 (7.27) | 171.97 (7.44) | 173.97 (7.74) | |
| Range | 160.30–191.90 | 157.50–189.50 | 157.500–191.900 | |
|
| 0.25 | |||
| Mean (SD) | 78.85 (13.90) | 75.28 (14.41) | 76.71 (14.24) | |
| Range | 57.00–117.40 | 50.30–107.30 | 50.30–117.40 | |
|
| 0.29 | |||
| Mean (SD) | 61.64 (9.36) | 59.45 (9.72) | 60.33 (9.59) | |
| Range | 49.04–84.81 | 43.08–87.94 | 43.08–87.94 | |
|
| 0.35 | |||
| Mean (SD) | 17.21 (6.73) | 15.82 (6.92) | 16.38 (6.84) | |
| Range | 6.43–32.59 | 1.57–35.14 | 1.57–35.14 | |
|
| 0.72 | |||
| N | 15 | 32 | 47 | |
| Mean (SD) | 86.63 (40.09) | 81.82 (45.15) | 84.17 (42.31) | |
| Range | 33.68–184.38 | 36.52–200.20 | 33.68–200.20 | |
|
| 0.09 | |||
| N | 10 | 21 | 31 | |
| Mean (SD) | 788.43 (282.30) | 654.68 (307.66) | 713.62 (301.76) | |
| Range | 377.12–1557.95 | 235.82–1589.58 | 235.82–1589.58 | |
|
| 0.04 | |||
| N | 16 | 33 | 49 | |
| Mean (SD) | 24.50 (9.25) | 19.42 (5.82) | 21.90 (8.01) | |
| Range | 14.10–45.67 | 7.71–27.56 | 7.71–45.67 | |
|
| 0.68 | |||
| N | 16 | 24 | 40 | |
| Mean (SD) | 8.37 (0.49) | 8.42 (0.43) | 8.40 (0.45) | |
| Range | 7.50–9.30 | 7.60–9.40 | 7.50–9.40 |
SD, standard deviation; P1NP, procollagen type 1N propeptide; CTX, C-terminal crosslinking telopeptide of type 1 collagen, kg, kilogram; FM, fat mass; and FFM, fat-free mass; N, number in group.
Figure 2Timeline for outcome measures and interventions for this nine-week study.
Coefficients for each regression model. These coefficients are the values related to the significant models for predicting bone formations and resorptions and can be used to predict these outcomes. Coefficients are presented as coefficient and 95% CI (lower, upper).
| Parameter | P1NP | CTX |
|---|---|---|
| (Intercept) | 87.77 *** | 767.51 *** |
| (74.68, 100.85) | (664.41, 870.60) | |
| Age (years) | −4.39 ** | −26.63 * |
| (−7.28, −1.50) | (−49.35, -3.90) | |
| FM (kg) | −3.06 *** | −11.54 |
| (−4.63, −1.48) | (−23.37, 0.29) | |
| Ethnicity (CC/Other) | −15.54 | −110.29 |
| (−34.29, 3.21) | (−248.26, 27.67) | |
| Run Time (s) | −0.93 | |
| (−2.12, 0.26) | ||
| N | 42 | 59 |
| R2 | 0.48 | 0.32 |
CI, confidence interval; P1NP, procollagen type 1N propeptide; CTX, C-terminal crosslinking telopeptide of type 1 collagen; kg, kilogram; CC, Caucasian; and s, seconds. *** p < 0.001, ** p < 0.01, and * p < 0.05.
Summary of effect sizes for supplement groups across each physiological biomarker.
| Variable | Mean Diff (SD) | Effect Size (95% CI) | Category |
|---|---|---|---|
|
| |||
| WP | 3.577 (23.639) | 0.084 (−0.168 to 0.337) | Negligible |
| CHO | 5.857 (23.343) | 0.135 (−0.098 to 0.368) | Negligible |
|
| |||
| WP | −10.513 (262.353) | −0.040 (−0.458 to 0.378) | Negligible |
| CHO | 14.752 (236.728) | 0.043 (−0.236 to 0.322) | Negligible |
|
| |||
| WP | 0.006 (0.060) | 0.088 (-0.347 to 0.523) | Negligible |
| CHO | 0.016 (0.044) | 0.342 (-0.082 to 0.766) | Small |
|
| |||
| WP | −0.138 (0.511) | −0.333 (−0.981 to 0.316) | Small |
| CHO | −0.067 (0.440) | −0.142 (−0.53 to 0.245) | Negligible |
|
| |||
| WP | 3.255 (6.142) | 0.380 (0.024 to 0.735) | Small |
| CHO | 4.722 (3.814) | 0.965 (0.559 to 1.371) | Large |
WP, whey protein; CHO, carbohydrate; P1NP (bone formation), procollagen type 1N propeptide; CTX (bone resorption), C-terminal crosslinking telopeptide of type 1 collagen; and ratio (formation/resorption ratio). Cohen’s D effect sizes; SD, standard deviation; and CI, confidence interval.
Figure 3Physiological biomarkers of bone health across the initial entry training (IET). P1NP, procollagen type 1N propeptide and CTX, C-terminal crosslinking telopeptide of type 1 collagen.